Pair page
Gonadorelin with Triptorelin
Mechanism-tag overlap and published literature for Gonadorelin and Triptorelin, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.
Mechanism overlap
Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.
gnrhsynthetic-gonadotropin-releasing-hormone
decapeptidegnrh-super-agonist
Co-administration notes from the literature
Verbatim summary text pulled from each compound's profile data. Researchers studying Gonadorelin and Triptorelin have published these mechanism-level observations. Not a co-administration recommendation.
Endogenous-sequence GnRH used in pulsatile dosing to maintain HPG-axis tone. Mechanistically opposite to triptorelin's sustained-exposure suppression. Used for HPG maintenance during TRT; not combined with triptorelin.
Quick facts
Gonadorelin
Triptorelin
Literature table
Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.
| Year | Compound | Source | Finding |
|---|---|---|---|
| 2021 | Gonadorelin | Kohn TP, Louis MR, Pickett SM, Lindgren MC, Kohn JR, Pastuszak AW, Lipshultz LI. Effects of subcutaneous gonadotropin-releasing hormone administration on serum hormonal concentrations, semen parameters, and sperm retrieval in men with hypogonadism undergoing testosterone therapy… PMID 33705811 | human study |
| 2002 | Gonadorelin | Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87(9):4128-4136. PMID: 12213860. PMID 12213860 | human study |
| 1994 | Gonadorelin | Filicori M, Flamigni C, Dellai P, Cognigni G, Michelacci L, Arnone R, Sambataro M, Falbo A. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab. 1994;79(4):1215-1220. PMID: 7962300. PMID 7962300 | human study |
| 1986 | Gonadorelin | Santoro N, Filicori M, Crowley WF. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev. 1986;7(1):11-23. PMID: 3082643. (Pulsatile GnRH therapy review.) PMID 3082643 | human study |
| 1982 | Gonadorelin | Hoffman AR, Crowley WF. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med. 1982;307(20):1237-1241. PMID: 6811941. (Pivotal pulsatile GnRH clinical paper.) PMID 6811941 | human study |
| 1971 | Gonadorelin | Matsuo H, Baba Y, Nair RM, Arimura A, Schally AV. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun. 1971;43(6):1334-1339. PMID: 4936338. (GnRH primary structure.) PMID 4936338 | preclinical, in vivo |
| 1971 | Gonadorelin | Schally AV, Arimura A, Baba Y, Nair RM, Matsuo H, Redding TW, Debeljuk L. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43(2):393-399. PMID: 4930263. (Schally GnRH isolation paper — Nobel Prize 1977.) PMID 4930263 | mechanism / discovery |
| 2026 | Gonadorelin | WADA Prohibited List 2026. World Anti-Doping Agency. wada-ama.org. (Gonadorelin banned in males under S2.2.) | regulatory / registry |
| — | Gonadorelin | FDA. Factrel (gonadorelin hydrochloride) Prescribing Information. FDA.gov. Wyeth Ayerst (discontinued). (Historical FDA approval reference.) | regulatory / registry |
| — | Gonadorelin | FDA. Lutrepulse / Lutrelef (gonadorelin acetate) Prescribing Information. FDA.gov. Ferring (discontinued). (Historical FDA pulsatile-pump approval.) | regulatory / registry |
| 2015 | Gonadorelin | Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. PMID: 25337841. (TRT fertility preservation review — HCG context.) PMID 25337841 | research article |
| 2014 | Gonadorelin | Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271-1279. PMID: 24636400. (Context for modern HPG preservation strategies.) PMID 24636400 | research article |
| 2011 | Triptorelin | Crawford ED, Tombal B, Miller K, Boccon-Gibod L, Schröder F, Shore N, Moul JW, Jensen JK, Olesen TK, Persson BE. A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostat… PMID 21788033 | human trial, Phase 3 |
| 2008 | Triptorelin | Klotz L, Boccon-Gibod L, Shore ND, Andreou C, Persson BE, Cantor P, Jensen JK, Olesen TK, Schröder FH. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer. BJU Int. 2008;102(11):15… PMID 19035858 | human trial, Phase 3 |
| 2005 | Triptorelin | Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20(5):1213-1220. PMID: 15689345. PMID 15689345 | human trial |
| 2006 | Triptorelin | Carel JC, Blumberg J, Seymour C, Adamsbaum C, Lahlou N; Triptorelin 3-month CPP Study Group. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. Eur J Endocrinol. 2006;154(1):119-124. PMID: 16382001. PMID 16382001 | human study |
| 2003 | Triptorelin | Heyns CF, Simonin MP, Grosgurin P, Schall R, Porchet HC; South African Triptorelin Study Group. Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU Int. 2003;92(3):226-231. PMID: 12887479. PMID 12887479 | human study |
| 2025 | Triptorelin | World Anti-Doping Agency. 2025 Prohibited List. Section S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics. WADA, 2025. | regulatory / registry |
| — | Triptorelin | U.S. Food and Drug Administration. Trelstar (triptorelin pamoate for injectable suspension) Prescribing Information. Verity Pharmaceuticals. FDA.gov. | regulatory / registry |
| 2020 | Triptorelin | Lundy SD, Sabanegh ES Jr. Non-classical forms of male infertility: triptorelin in recovery of hypogonadotropic hypogonadism secondary to anabolic-androgenic steroid use. Transl Androl Urol. 2020;9(2):166-172. PMID: 32420127. PMID 32420127 | research article |
| 2015 | Triptorelin | Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, et al.; SOFT Investigators. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2015;372(5):436-446. PMID: 25495490. PMID 25495490 | research article |
| 2012 | Triptorelin | Jungwirth A, Diemer T, Dohle GR, et al. European Association of Urology Guidelines on Male Infertility. Eur Urol. 2012;62(2):324-332. PMID: 22591628. PMID 22591628 | research article |
| 2010 | Triptorelin | Shore ND, Crawford ED. Intermittent androgen deprivation therapy: redefining the standard of care? Rev Urol. 2010;12(1):1-11. PMID: 20428290. PMID 20428290 | research article |
| 2007 | Triptorelin | Engel JB, Schally AV. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab. 2007;3(2):157-167. PMID: 17237842. PMID 17237842 | research article |
Related pair pages
More research context
Frequently asked
Have Gonadorelin and Triptorelin been studied together?
Researchers have published mechanistic-level co-administration discussion of Gonadorelin and Triptorelin. No human co-administration trials are catalogued in the Kalios profiles. The pair page lists each compound's classified literature; full citations sit on each individual profile.
What mechanisms do Gonadorelin and Triptorelin share?
Gonadorelin and Triptorelin do not share a specific mechanism tag on their Kalios profiles. They appear on the same pair page because at least one profile lists the other in its co-administration data.
What is the FDA status of Gonadorelin and Triptorelin?
Gonadorelin: Historical approval (Factrel, Lutrepulse); compounded off-label currently. Triptorelin: Approved (Trelstar, 2000). FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.
Where can I find the full research on Gonadorelin and Triptorelin?
Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the Gonadorelin profile and the Triptorelin profile. The Kalios Stack Research Tool hub lists every compound covered.
Last updated: April 2026